Search

Author/Creator Loy, Megan

1. A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins. (24th November 2022)

Authors:
Catapano, Alberico L.; Vrablik, Michal; Karpov, Yuri; Berthou, Baptiste; Loy, Megan; Baccara-Dinet, Marie
Journal:
Journal of cardiovascular pharmacology and therapeutics
Issue:
Volume 27(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Alirocumab after acute coronary syndrome in patients with a history of heart failure. (18th December 2021)

Authors:
White, Harvey D; Schwartz, Gregory G; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Chiang, Chern-En; Diaz, Rafael; Goodman, Shaun G; Jukema, Johan Wouter; Loy, Megan; Pagidipati, Neha; Pordy, Robert; Ristić, Arsen D; Zeiher, Andreas M; Wojdyla, Daniel M; Steg, Philippe Gabriel
Journal:
European heart journal
Issue:
Volume 43:Number 16(2022)
Page Start:
1554
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study. (30th November 2020)

Authors:
Gaudet, Daniel; López-Sendón, José Luis; Averna, Maurizio; Bigot, Grégory; Banach, Maciej; Letierce, Alexia; Loy, Megan; Samuel, Rita; Manvelian, Garen; Batsu, Isabela; Henry, Patrick
Journal:
European journal of preventive cardiology
Issue:
Volume 28:Number 17(2021)
Page Start:
1864
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗